Finger Lakes Addictions Counseling and Recovery Agency/FLACRA OP 1
-
Services:
- In-network prescribing entity
- Other contracted prescribing entity
- No formal relationship with prescribing entity
- Federally Qualified Health Center
- State Substance use treatment agency
- Sliding fee scale (fee is based on income and other factors)
- Outpatient methadone/buprenorphine or naltrexone treatment
- Outpatient
- Regular outpatient treatment
- Drug or alcohol urine screening
- Drug and alcohol oral fluid testing
- Breathalyzer or blood alcohol testing
- Naloxone and overdose education
- Aftercare/continuing care
- Discharge Planning
- Adult women
- Adult men
- Vaping not permitted
- Mental health services
- Domestic violence services, including family or partner
- Social skills development
- Case management service
- Early intervention for HIV
- Transportation assistance
- Private non-profit organization
- Screening for substance use
- Interim services for clients
- Screening for mental disorders
- Screening for tobacco use
- Comprehensive mental health assessment
- Outreach to persons in the community
- Comprehensive substance use assessment
- Relapse prevention with naltrexone
- Accepts clients using MAT but prescribed elsewhere
- Buprenorphine maintenance
- Prescribes naltrexone
- Prescribes buprenorphine
- This facility administers/prescribes medication for alcohol use disorder
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- Substance use disorder education
- Health education services other than HIV/AIDS or hepatitis
- HIV or AIDS education, counseling, or support
- Individual counseling
- Family counseling
- Marital/couples counseling
- Smoking/vaping/tobacco cessation counseling
- Hepatitis education, counseling, or support
- Group counseling
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Substance use treatment
- Disulfiram
- Naltrexone (oral)
- Buprenorphine (extended-release, injectable)
- Clonidine
- Medication for mental disorders
- Non-nicotine smoking/tobacco cessation
- Nicotine replacement
- Naltrexone (extended-release, injectable)
- Buprenorphine with naloxone
- Acamprosate (Campral®)
- Buprenorphine without naloxone
- Smoking not permitted
- In-network prescribing entity
- No formal relationship with prescribing entity
- Relapse prevention
- Anger management
- Cognitive behavioral therapy
- Brief intervention
- Motivational interviewing
- Telemedicine/telehealth therapy
- Substance use disorder counseling
- Trauma-related counseling
- Contingency management/motivational incentives
- Female
- Male
- Assistance with obtaining social services
- Housing services
- Employment counseling or training
- Mentoring/peer support
- Recovery coach
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Private health insurance
- Medicaid
- State-financed health insurance plan other than Medicaid
- Federal military insurance (e.g., TRICARE)
- Cash or self-payment
External Source of Medications Used for Alcohol Use Disorder Treatment
License/Certification/Accreditation
Payment Assistance Available
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Testing
Transitional Services
Special Programs/Groups Offered
Facility Vaping Policy
Ancillary Services
Facility Operation (e.g., Private, Public)
Assessment/Pre-treatment
Type of Opioid Treatment
Type of Alcohol Use Disorder Treatment
Education and Counseling Services
Type of Care
Pharmacotherapies
Facility Smoking Policy
External Opioid Medications Source
Treatment Approaches
Gender Accepted
Recovery Support Services
Opioid Medications used in Treatment
Payment/Insurance/Funding Accepted